Page 10 of 18 SEC Filing CUSIP No. 67552A108 Page 10 of 18
Introductory Note: This Schedule 13G is filed on behalf of Venrock Healthcare Capital Partners, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP”), VHCP Co-Investment Holdings, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment”), Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment II”), VHCP Management, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II” and collectively with VHCP, VHCP Co-Investment, VHCP II, VHCP Co-Investment II and VHCP Management, the “Venrock Entities”), Anders Hove (“Hove”) and Bong Koh (“Koh”) in respect of shares of common stock of Ocera Therapeutics, Inc. Item 1. (a) Name of Issuer
Ocera Therapeutics, Inc. (b) Address of Issuer’s Principal Executive Offices
525 University Avenue, Suite 610 Palo Alto, CA 94301 Item 2. (a) Name of Person Filing
Venrock Healthcare Capital Partners, L.P. VHCP Co-Investment Holdings, LLC Venrock Healthcare Capital Partners II, L.P. VHCP Co-Investment Holdings II, LLC VHCP Management, LLC VHCP Management II, LLC Anders Hove Bong Koh (b) Address of Principal Business Office or, if none, Residence
New York Office: Palo Alto Office: Boston Office: 530 Fifth Avenue 3340 Hillview Avenue 470 Atlantic Avenue 22nd Floor Palo Alto, CA 94304 4th Floor New York, NY 10036 Boston, MA 02210
(c) Citizenship
Each of the Venrock Entities was organized in Delaware. Hove and Koh are both United States citizens. (d) Title of Class of Securities
Common Stock, $0.00001 par value per share (e) CUSIP Number
67552A108 Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. 67552A108 | Page 10 of 18 |
Introductory Note: This Schedule 13G is filed on behalf of Venrock Healthcare Capital Partners, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP”), VHCP Co-Investment Holdings, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment”), Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment II”), VHCP Management, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II” and collectively with VHCP, VHCP Co-Investment, VHCP II, VHCP Co-Investment II and VHCP Management, the “Venrock Entities”), Anders Hove (“Hove”) and Bong Koh (“Koh”) in respect of shares of common stock of Ocera Therapeutics, Inc.
Item 1.
| (a) | Name of Issuer |
Ocera Therapeutics, Inc.
| (b) | Address of Issuer’s Principal Executive Offices |
525 University Avenue, Suite 610
Palo Alto, CA 94301
Item 2.
| (a) | Name of Person Filing |
Venrock Healthcare Capital Partners, L.P.
VHCP Co-Investment Holdings, LLC
Venrock Healthcare Capital Partners II, L.P.
VHCP Co-Investment Holdings II, LLC
VHCP Management, LLC
VHCP Management II, LLC
Anders Hove
Bong Koh
| (b) | Address of Principal Business Office or, if none, Residence |
| New York Office: | Palo Alto Office: | Boston Office: | ||
| 530 Fifth Avenue | 3340 Hillview Avenue | 470 Atlantic Avenue | ||
| 22nd Floor | Palo Alto, CA 94304 | 4th Floor | ||
| New York, NY 10036 | Boston, MA 02210 | |||
| (c) | Citizenship |
Each of the Venrock Entities was organized in Delaware. Hove and Koh are both United States citizens.
| (d) | Title of Class of Securities |
Common Stock, $0.00001 par value per share
| (e) | CUSIP Number |
67552A108
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
